Tailin Biotech: Announcement on Obtaining Patent Certificates and Computer Software Copyright Registration Certificates
Tailin Biotech: Public Opinion Management System
Tailin Biotech: Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Supervisors
Tailin Biotech: Announcement on the forecast for daily related transactions in 2025
Tailin Biotech: Verification Opinions of Great Wall Securities Co., Ltd. on Zhejiang Tailin Biotechnology Co., Ltd.\'s 2025 daily related transaction forecast
Tailin Biotech: Verification Opinions of Great Wall Securities Co., Ltd. on the extension of Zhejiang Tailin Biotechnology Co., Ltd.\'s fund-raising investment project to issue convertible corporate bonds to unspecified targets
Tailin Biotech: Announcement on the extension of a fund-raising investment project to issue convertible corporate bonds to unspecified targets
Tailin Biotech: Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Directors
Tailin Biotech: Announcement on the redemption results of “Tailin Bonds Transfer”
Tailin Biotech: Announcement on delisting of “Tailin Bonds Transfer”
Tailin Biotech: Important reminder that “Tailin Bonds Transfer” will stop the stock conversion and the last half of the trading day before the redemption date
Tailin Biotech: Important reminder that “Tailin Bonds Transfer” is about to stop stock conversion and the last trading day before the redemption date
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Important reminder on the implementation of the “Tailin Bonds Transfer” redemption and the imminent cessation of stock conversion
Tailin Biotech: Announcement on passively diluting the shareholding ratio of controlling shareholders, actual controllers, and their co-actors by more than 1%
Tailin Biotech: Simplified Equity Change Report
Tailin Biotech: An indicative announcement on the cumulative percentage of changes in the rights and interests of controlling shareholders, actual controllers, and their concerted actors to reach 5%
Tailin Biotech: Important reminder on the implementation of the “Tailin Bonds Transfer” redemption and the imminent cessation of stock conversion
Tailin Biotech: Announcement on the cumulative conversion amount of “Tailin Bonds Transfer” reaching 10% of the total amount of shares issued by the company before the conversion
Tailin Biotech: Important reminder on the implementation of “Tailin Bonds Transfer” redemption and the impending cessation of trading
No Data